Cite

HARVARD Citation

    Nijenhuis, C. et al. (2017). Clinical Pharmacokinetics of Vemurafenib in BRAF‐Mutated Melanoma Patients. Journal of clinical pharmacology. pp. 125-128. [Online]. 
  
Back to record